JAOA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toffol, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toffol, G.
Journal of the American Osteopathic Association, Vol 90, Issue 5, 435-435
Copyright © 1990 by American Osteopathic Association

Articles

Aspirin and stroke prevention: how much?

GJ Toffol

Media attention concerning aspirin and the prevention of heart attack has been great, but there has been no similar attention to the subject of aspirin and stroke prevention. Clinical information is available in the literature concerning aspirin dosage and stroke prevention following transient ischemic attack (TIA). However, confusion still exists regarding appropriate dosing as well as the effectiveness of other antiplatelet agents. This review focuses on the mechanism of action of aspirin and cites the rationale provided by clinical trials for a recommendation of 1300 mg of aspirin per day as the sole orally administered antiplatelet agent.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Osteopathic Association.